MYFEMBREE
MYFEMBREE
Approved
DIN Number
02541742
Drug Class
Human
Market Date
Jan 29, 2024
Company
HC
Sumitomo Pharma Switzerland GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02541742
AIG Number0365021001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H01CC54 RELUGOLIX, ESTRADIOL AND NORETHISTERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:18.04
Health Canada Classification
ACTIVE INGREDIENTS (3)
ESTRADIOLActive
Strength: 1 MG
Monograph: ESTRADIOL
NORETHINDRONE ACETATEActive
Strength: 0.5 MG
Monograph: NORETHINDRONE ACETATE
RELUGOLIXActive
Strength: 40 MG
Monograph: RELUGOLIX